Cevimeline
1 NDC across 1 manufacturer|1 Generic,0 Brand
Cevimeline is used to treat rheumatoid arthritis, parotitis and xerostomia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Cevimeline is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $0.71 to $0.71 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$0.71 – $0.71
per EA
7d Activity
avg +6.4% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing CEVIMELINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CEVIMELINE HCL 30 MG CAPSULE | $0.7080 per EA | +6.36% |
Frequently Asked Questions
What is Cevimeline used to treat?
Cevimeline is used to treat rheumatoid arthritis, parotitis and xerostomia, per the National Library of Medicine's MED-RT classification.
How many Cevimeline products are on the market?
The Cevimeline drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Cevimeline?
NADAC reference prices for Cevimeline range from $0.7080 to $0.7080 per EA.
Which manufacturers make Cevimeline?
1 manufacturer lists Cevimeline in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (1).
How has the price of Cevimeline changed recently?
Over the past 7 days, 1 Cevimeline NDC rose and 0 fell, with a market-wide average change of +6.4%.